Scott Powell | IR |
Cameron Reynolds | Founder, Group CEO |
Tom Butera | CEO, Volition Veterinary |
Terig Hughes | CFO |
Michael Okunewitch | Maxim Group |
Bruce Jackson | The Benchmark Company |
Steven Ralston | Zacks |
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's Third Quarter 2022 Earnings Conference Call. [Operator Instructions] This conference is being recorded today, November 15, 2022. I'd now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations.